BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15489486)

  • 1. Epiphora as a side effect of topical mitomycin C.
    Kopp ED; Seregard S
    Br J Ophthalmol; 2004 Nov; 88(11):1422-4. PubMed ID: 15489486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ditta LC; Shildkrot Y; Wilson MW
    Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical mitomycin C for the treatment of conjunctival tumor.
    Ozcan AA; Sizmaz S; Yagmur M
    Ophthalmologica; 2007; 221(1):14-7. PubMed ID: 17183195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double lacrimal puncta: clinical presentation and potential mechanisms of epiphora.
    Satchi K; McNab AA
    Ophthalmology; 2010 Jan; 117(1):180-183.e2. PubMed ID: 19875171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia.
    Billing K; Karagiannis A; Selva D
    Am J Ophthalmol; 2003 Oct; 136(4):746-7. PubMed ID: 14516822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
    Khong JJ; Muecke J
    Br J Ophthalmol; 2006 Jul; 90(7):819-22. PubMed ID: 16672325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
    Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
    Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative mitomycin C use during filtration surgery and lacrimal drainage system obstruction.
    Kashkouli MB; Parvaresh MM; Mirzajani H; Astaraki A; Falavarjani KG; Ahadian A
    Am J Ophthalmol; 2009 Mar; 147(3):453-457.e1. PubMed ID: 19019341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periocular allergic contact dermatitis following topical Mitomycin C eye drop application.
    Cumurcu T; Sener S; Cavdar M
    Cutan Ocul Toxicol; 2011 Sep; 30(3):239-40. PubMed ID: 21309691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C in revision endoscopic dacryocystorhinostomy: a prospective randomized study.
    Penttilä E; Smirnov G; Seppä J; Kaarniranta K; Tuomilehto H
    Am J Rhinol Allergy; 2011; 25(6):425-8. PubMed ID: 22185749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The topical application of mitomycin C in the treatment of scar formation and stenosis in hollow organs of the head and neck: a field report].
    Bast F; Risteska K; Jovanovic S; Sedlmaier B
    Laryngorhinootologie; 2009 Aug; 88(8):528-33. PubMed ID: 19554503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.
    Russell HC; Chadha V; Lockington D; Kemp EG
    Br J Ophthalmol; 2010 Oct; 94(10):1316-21. PubMed ID: 20530655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
    Akpek EK; Ertoy D; Kalayci D; Hasiripi H
    Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    Finger PT; Czechonska G; Liarikos S
    Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
    Ramos-López JF; Martínez-Costa Pérez R; Cisneros Lanuza AL; Francés Muñoz E; Monte Boque E; Muñoz Gómez MC; López-Sánchez EV; Menezo Rozalén JL
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):375-8. PubMed ID: 15306963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired Obliteration of the Proximal Lacrimal Drainage System.
    Starks VS; Yoon MK
    Ophthalmic Plast Reconstr Surg; 2019; 35(4):342-345. PubMed ID: 30365474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    Dudney BW; Malecha MA
    Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
    Pe'er J; Frucht-Pery J
    Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults.
    Dolmetsch AM
    Ophthalmology; 2010 May; 117(5):1037-40. PubMed ID: 20079535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.